For the Inventor, By the Inventor

Enter inventor name

St Arnoult en Yvelines, France

Pascal George

USPTO Granted Patents = 45

Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 280(Granted Patents)

Location History:

Vitry, FR (1985)
Vtry sur Seine, FR (1989)
Vitry sur Seine, FR (1983 - 1990)
St. Arnoult en Yvelines, BE (1990)
Vitry sur Seine, BE (1987 - 1991)
St. Arnoult-en-Yvelines, FR (1992 - 1993)
Saint Arnoult en Yveline, FR (1996)
St Arnoult en Yvelines, FR (1991 - 1997)
Saint Arnoult en Yvelines, FR (1996 - 2001)

Company Filing History:

Sanofi-synthelabo

Years Active: 1983-2001

Loading Chart...

Areas of Expertise:

Dopamine Receptors

Serotonin Receptors

Pyridoindole Derivatives

Naphthalene Derivatives

Peripheral Neuropathies

Piperazine Derivatives

Imidazopyridine

Anxiolytic Agents

Therapeutic Applications

Carboxamide Derivatives

Isoquinoline Derivatives

Therapeutically Useful Compounds

45 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6221879 - 8-azabicyclo[3.2.1] octane-3-methanamine derivatives as ligands of D2 and D3 dopamine and 5HT1A and 5HT2 serotonin receptors (2001-04-24),

2. 6075021 - 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and (2000-06-13),

3. 5929078 - 1-�2-(2,3-Dihydro-1H-inden-1-yl)ethyl!-4-(naphthalen-1-yl) piperazine, (1999-07-27),

4. 5922739 - 5-Naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutical (1999-07-13),

5. 5663183 - N-(3-Aminopropyl)-N-phenyl-5,6,7,8-tetrahydronaphthalene-2-carboxamide (1997-09-02),

6. 5652248 - Method of preventing peripheral neuropathies induced by anticancer agents (1997-07-29),

7. 5550162 - N-(-3-aminopropyl)-N-phenyl-5,6,7,8-tetrahydro-naphthalene-2-carboxamide (1996-08-27),

8. 5550125 - 3-(2-aminomethyl)-4-[3-trifluoromethyl)benzoyl]-3-4 (1996-08-27),

9. 5543421 - Method of treatment of peripheral neuropathies and central (1996-08-06),

10. 5530002 - 1-[2-(1H-inden-3-yl)ethyl]-4-(naphth-1-yl)piperazine derivatives, their (1996-06-25),

11. 5512590 - 5,6-dihydro-4h-imidazo 2',1':2,3!imidazo- 4,5,1-ij!quinoline and (1996-04-30),

12. 5466706 - 9H-imidazo[1,2-A]benzimidazole-3-acetamide derivatives, their (1995-11-14),

13. 5447928 - Benzoxazine derivatives and their application in therapy (1995-09-05),

14. 5420130 - 2-aminopyrazine-5-carboxamide derivatives, their preparation and their (1995-05-30),

15. 5418248 - 2-thienylimidazo[2,1-.beta.]benzothiazole-3-acetic acid derivatives, (1995-05-23),

Title: The Innovative Contributions of Pascal George

Introduction

Pascal George, based in St Arnoult en Yvelines, France, is a prominent inventor known for his substantial contributions to the field of pharmacology and medicinal chemistry. With a remarkable portfolio of 45 patents, George has made significant strides in the development of compounds that interact with important neurotransmitters in the human brain.

Latest Patents

Among his latest breakthroughs are innovations such as the 8-azabicyclo[3.2.1] octane-3-methanamine derivatives, which serve as ligands for D2 and D3 dopamine receptors as well as 5HT1A and 5HT2 serotonin receptors. Additionally, his work includes the development of 1H-pyrido[3,4-b]indole-4-carboxamide derivatives, showcasing his commitment to advancing medicinal chemistry through innovative synthesis and application.

Career Highlights

Throughout his career, Pascal George has been associated with prestigious companies, notably Synthelabo and Sanofi-Synthelabo. His time at these organizations has allowed him to focus on research and development, leading to numerous patent filings that contribute to advancements in therapeutic compounds.

Collaborations

Collaboration has been a cornerstone of George's career, as evidenced by his work with esteemed colleagues Mireille Sevrin and Jacques Froissant. These partnerships have fostered a creative environment where innovative ideas could flourish, further enhancing the development of groundbreaking pharmaceuticals.

Conclusion

Pascal George's dedication to innovation and his extensive patent portfolio underscore his impactful presence in the field of medicinal chemistry. His work continues to influence the development of new treatments, highlighting the importance of collaboration and research in advancing the boundaries of science and medicine.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…